BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35765945)

  • 1. PLCE1 is a poor prognostic marker and may promote immune escape from osteosarcoma by the CD70-CD27 signaling pathway.
    Huang L; Liao C; Wu H; Huang P
    Bosn J Basic Med Sci; 2022 Oct; 22(6):992-1004. PubMed ID: 35765945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of prognosis and immune function of CD70-CD27 signaling axis in pan-cancer.
    Kong F; Ye Q; Xiong Y
    Funct Integr Genomics; 2023 Jan; 23(1):48. PubMed ID: 36700974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines.
    Wang XK; Liao XW; Yang CK; Liu ZQ; Han QF; Zhou X; Zhang LB; Deng T; Gong YZ; Huang JL; Huang R; Han CY; Yu TD; Su H; Ye XP; Peng T; Zhu GZ
    J Cell Physiol; 2020 Oct; 235(10):7003-7017. PubMed ID: 32037547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression patterns and tight correlation of the PLCE1 and NF-κB signaling in Kazakh patients with esophageal carcinoma.
    Cui XB; Pang XL; Li S; Jin J; Hu JM; Yang L; Liu CX; Li L; Wen SJ; Liang WH; Chen YZ; Li F
    Med Oncol; 2014 Jan; 31(1):791. PubMed ID: 24307345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail.
    Zhai S; Liu C; Zhang L; Zhu J; Guo J; Zhang J; Chen Z; Zhou W; Chang T; Xu S; Qi Y; Zhuang T; Yu N; Wang W; Wang H; Yu S; Li X
    Neoplasia; 2017 Mar; 19(3):154-164. PubMed ID: 28147304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of phospholipase C epsilon-1 in gastric cancer and its association with prognosis].
    Yu S; Wu F; Guo K; Shao Q; Tao H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):378-82. PubMed ID: 24760650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Variants in EGFR/PLCE1 Pathway Are Associated with Prognosis of Esophageal Squamous Cell Carcinoma after Radical Resection.
    Wang YL; Yuan Y; Luo XX; Hu GY; Gong P
    Curr Med Sci; 2019 Jun; 39(3):385-390. PubMed ID: 31209807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.
    Cui XB; Li S; Li TT; Peng H; Jin TT; Zhang SM; Liu CX; Yang L; Shen YY; Li SG; Li N; Li Y; Hu JM; Jiang JF; Suo J; Qi Y; Liang WH; Wang LH; Dang HW; Li L; Cao WW; Wei Y; Laibo-Yin ; Wu CY; Yuan XL; Zhou H; Zheng Y; Chen YZ; Li F
    Oncotarget; 2016 Jan; 7(2):1777-95. PubMed ID: 26657507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-145 performs as a tumor suppressor in human esophageal squamous cell carcinoma by targeting phospholipase C epsilon 1.
    Tang C; He JY; Yu C; Wang PJ; Huang SH; Zheng HJ; Yan DQ; Zhang JH; Li Y
    J Cell Biochem; 2019 Jun; 120(6):10678-10687. PubMed ID: 30652343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts.
    Zhang Y; Liu Z; Yang X; Lu W; Chen Y; Lin Y; Wang J; Lin S; Yun JP
    Theranostics; 2021; 11(3):1473-1492. PubMed ID: 33391546
    [No Abstract]   [Full Text] [Related]  

  • 13. PLCE1 as a diagnostic and prognostic biomarker by promoting the growth and progression of oral squamous cell carcinoma.
    Abulaiti Z; Chen L; Xiao Q; Aimaier A; Ma Y; He S; Zhang J; Xu J; Cui X
    J Oral Pathol Med; 2022 Oct; 51(9):771-779. PubMed ID: 36065133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospero homeobox 1 promotes proliferation, migration, and invasion of osteosarcoma cells and its clinical significance.
    Liu D; Wang R; Wang Y; Wang Y; Wang L
    Bioengineered; 2022 Feb; 13(2):2259-2271. PubMed ID: 35030967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
    Han Y; Zhao X; Sun Y; Sui Y; Liu J
    J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of hsa_circ_0007534 predicts unfavorable prognosis for osteosarcoma and regulates cell growth and apoptosis by affecting AKT/GSK-3β signaling pathway.
    Li B; Li X
    Biomed Pharmacother; 2018 Nov; 107():860-866. PubMed ID: 30142548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Li Y; Luan C
    Yonsei Med J; 2018 Dec; 59(10):1159-1165. PubMed ID: 30450849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1.
    Han N; Zhao W; Zhang Z; Zheng P
    Biochem Biophys Res Commun; 2016 Jan; 470(1):175-180. PubMed ID: 26773497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer.
    Wang X; Zhou C; Qiu G; Yang Y; Yan D; Xing T; Fan J; Tang H; Peng Z
    Med Oncol; 2012 Jun; 29(2):1051-8. PubMed ID: 21667163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.